Follow the people · Insider

JS

John R. Stuelpnagel

Insider · Director · TXG

John R. Stuelpnagel files insider transactions with the SEC as a director of 10x Genomics (TXG). We hold 2 disclosed purchases and sales filed since 3 January 2006, 2 of them in the last 90 days.

  • Files forTXG
  • Disclosed buys and sells2 in all, 2 in the last 90 days
  • Last disclosure8 September 2026

Positions held

2 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 16 September 20193 September 2026Director · 10x Genomics (TXG)215 Form 4 lines · source: SEC Form 4
  • Filed 29 December 200527 March 2008Sr VP and COO · Illumina (ILMN)58 Form 4 lines · source: SEC Form 4

Everything they disclosed

120 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.